Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 ,inter alia, to consider and approve Nureca Limited has informed the exchange ....
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited has informed the stock exchanges (BSE and NSE) about a board meeting scheduled for Thursday, October 16, 2025. The board will consider and approve the un-audited financial results, both standalone and consolidated, for the second quarter and half year ended September 30, 2025. The intimation was filed on October 10, 2025 under SEBI Listing Regulations 29 and 30. Nishu Kansal, Company Secretary & Compliance Officer, signed the letter. The company's BSE scrip code is 543264 and NSE symbol is NURECA.
This is a routine SEBI-mandated advance notice with no direct effect on the stock. Investors should watch for the Q2 FY26 results on or after October 16, 2025, as actual numbers versus street expectations will be the next potential price catalyst.